Old Web
English
Sign In
Acemap
>
Paper
>
216 Preclinical characterization of EMD 1214063 - a selective c-Met kinase inhibitor in clinical phase 1
216 Preclinical characterization of EMD 1214063 - a selective c-Met kinase inhibitor in clinical phase 1
2010
O. Schadt
Dieter Dorsch
Frank Stieber
Andree Blaukat
Friedhelm Bladt
Claus Fittschen
Michael Meyring
Manja Friese-Hamim
Christine Knuehl
Ulrich Graedler
Keywords:
Pathology
C-Met
Cancer research
Kinase
Medicine
Pharmacology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]